查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971699

動物病毒檢測試劑盒市場：按技術、動物類型、檢體類型、病毒類型、最終用戶和分銷管道分類－全球預測，2026-2032年

Animal Virus Detection Kit Market by Technology, Animal Type, Sample Type, Virus Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

動物病毒檢測試劑盒市場預計到 2025 年將達到 15.5 億美元，到 2026 年將成長到 17.1 億美元，到 2032 年將達到 32.7 億美元，複合年成長率為 11.28%。

主要市場統計數據
基準年 2025 15.5億美元
預計年份：2026年 17.1億美元
預測年份：2032年 32.7億美元
複合年成長率 (%) 11.28%

針對不同獸醫和監測生態系統中動物病毒診斷試劑盒的創新和部署，制定迫切的策略框架。

目前動物病毒檢測試劑盒的發展正處於技術創新、公共衛生緊迫性和產業轉型三者交會的階段。對快速檢測、早期控制和跨動物及人類健康領域的綜合監測的需求，正迅速推動診斷能力從以往局限於中心實驗室轉向可現場部署的形式。隨著病原體的不斷出現和再次出現，從獸醫診所到研究機構的相關人員必須應對複雜的平台、檢體類型和法規環境，才能有效控制疾病並保障供應鏈安全。

技術突破和營運創新如何迅速重新定義動物健康領域診斷性能的預期和部署策略？

近年來，一系列變革正在改變動物病毒檢測試劑盒的研發、檢驗和應用方式。分子生物學的進步，特別是基於CRISPR的診斷技術的成熟和等溫擴增技術的改進，降低了高靈敏度和快速檢測的技術門檻，使得在遠離集中式參考實驗室的情況下進行分散式檢查成為可能。同時，新一代定序平台變得更加普及和柔軟性，能夠實現對病原體的全面監測和對新型變異株的快速鑑定。這為診斷設計和疫情應對提供了寶貴的資訊。

評估美國關稅調整對動物診斷試劑盒採購和商業化的廣泛供應鏈、定價和策略影響。

改變跨境貿易動態的政策變化將對動物病毒檢測試劑盒的供應鏈和商業策略產生直接而顯著的影響。美國在2025年實施的關稅調整迫使製造商和經銷商重新評估其籌資策略、製造地和定價模式。這些變化凸顯了本地生產能力和戰略儲備的重要性日益增加，它們是緩解進口成本波動、確保酵素、試劑盒和試劑等關鍵診斷材料持續供應的有效手段。

以市場區隔主導導向的綜合產品策略和市場推出方法，整合技術、動物類型、檢體物流和分銷管道，以實現成功的診斷。

了解細分市場的細微差別對於研發和銷售部門至關重要，這有助於他們將產品功能與最終用戶需求和實際營運狀況相匹配。從技術角度來看，這包括：基於 CRISPR 的方法，使用 Cas12/Cas13 變體，兼具高特異性和快速側向流動整合的潛力；競爭性、間接和夾心式酵素免疫分析法，它們仍然是抗原和抗體檢測的基礎；恒溫環型核酸擴增平台，包括側向流動 LAMP 和即時LAMP，無需複雜的熱迴圈儀即可實現現場擴增；下一代定序技術，分為長讀長和短讀長策略，既可用於全面的病原體發現，也可用於靶向監測；以及聚合酵素鏈鎖反應平台，分為數位 PCR 和即時PCR，它們不斷樹立分析靈敏度的新標準。

全球獸醫市場中部署模式和基礎設施的區域差異決定了檢驗通路、分銷模式和監測合作。

區域趨勢正在塑造不同的技術採納曲線、監管預期和供應鏈韌性，這需要企業認真考慮。在美洲，成熟的檢查室網路、健全的獸醫基礎設施和一體化的供應鏈促進了高通量平台和檢驗檢測組合的採用，而偏遠的農業地區則同時需要照護現場解決方案。在歐洲、中東和非洲，監管的多樣性和檢測能力的差異為靈活的檢驗策略和模組化平台提供了機遇，這些策略和平台可以適應當地的核准流程和資源限制。此外，這些地區內不同的農業實踐凸顯了對高度適應性的檢體採集方法和培訓計劃的需求。

結合快速檢測創新、嚴格的檢驗方法、可擴展的生產系統和促進應用的夥伴關係生態系統，形成競爭優勢。

該領域的競爭動態更取決於能否將技術創新與實際檢驗、清晰的監管框架以及可靠的供應鏈相結合，而非單純的規模優勢。主要企業展現出在保持快速的檢測方法開發、可靠的分析和臨床檢驗以及嚴格的品管的同時，實現規模化生產的能力。檢測開發公司、儀器製造商和分銷商之間的合作十分普遍，透過整合試劑盒和耗材、儀器以及數位化報告工具，能夠更快地進入市場並提供更廣泛的服務。

為了將診斷技術的創新轉化為在各種環境下穩健的供應模式、快速檢驗和最終用戶的永續採用，企業必須實施可操作的策略措施。

產業領導者應優先採取一系列具體行動，將技術潛力轉化為永續的實際應用效果。首先，投資支援多種檢測化學方法的模組化平台，可以縮短新產品上市時間，並為客戶提供面向未來的解決方案。其次，建構區域性生產和分銷冗餘體系，可以降低關稅導致的成本飆升和供應中斷風險，同時透過有針對性的庫存策略確保關鍵試劑的持續供應。第三，透過系統性的現場測試和第三方評估加快檢驗，可以增強診斷實驗室和大型生產商的信心，並縮短採購週期。

為了支持實際見解，我們採用穩健的混合方法研究途徑，結合專家訪談、綜合技術檢驗、供應鏈映射和監管分析。

本分析所依據的研究結合了結構化的一手和二手研究，以確保其兼具深度和實用性。一手研究包括對獸醫診斷專家、檢查室經理、農場經理和研發負責人進行訪談，以了解最終用戶的優先事項、檢驗挑戰和採購偏好。這些定性研究結果與通訊協定審查、同行評審文獻和監管指南進行三角驗證，從而確定技術成熟度等級和檢驗要求。透過對檢測檢驗研究和儀器規格的綜合分析，評估了技術性能屬性，以評估其在各種檢體類型和使用情境中的適用性。

我們綜合考慮了診斷效能、供應鏈韌性和相關人員合作，作為決定動物健康監測未來成功的關鍵因素。

病原體出現、技術進步和貿易格局變化帶來的多重壓力，要求診斷試劑開發商、經銷商和終端用戶通力合作。動物病毒檢測試劑盒領域的成功取決於能否提供分析性能可靠且適用於各種檢體基質和終端用戶環境的操作性檢測方法。同樣重要的是建立具有韌性的價值鍊和適應性強的商業策略，以應對政策變化和區域差異。結合嚴格的現場檢驗和針對性培訓，這些要素能夠創造極具吸引力的價值提案，從而加速產品應用並加強監測系統。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物病毒檢測試劑盒市場：依技術分類

  • CRIPR 基地
    • Cas12
    • Cas13
  • 酵素免疫分析法
    • 競爭對手
    • 間接法
    • 三明治法
  • 恒溫環型核酸擴增法
    • 側向流動燈
    • 即時 LAMP
  • 下一代定序
    • 長週期
    • 短線
  • 聚合酵素鏈鎖反應
    • 數位PCR
    • 即時PCR

第9章：動物病毒檢測試劑盒市場：依動物類型分類

  • 水產養殖
    • 魚
    • 蝦
  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 羊
    • 豬
  • 家禽
    • 雞
    • 鴨子
    • 火雞

第10章：動物病毒檢測試劑盒市場：依檢體類型分類

  • 血
    • 電漿
    • 血清
    • 全血
  • 屎
  • 拭子
    • 鼻腔
    • 口服
    • 直腸
  • 組織

第11章：動物病毒檢測試劑盒市場：依病毒類型分類

  • DNA
    • 信封類型
    • 非信封式
  • RNA
    • 信封類型
    • 非信封式

第12章：動物病毒檢測試劑盒市場：依最終用戶分類

  • 診斷實驗室
    • 私人考試機構
    • 公共衛生實驗室
  • 農場
  • 研究機構
  • 動物醫院

第13章：動物病毒檢測試劑盒市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上平台

第14章：動物病毒檢測試劑盒市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：動物病毒檢測試劑盒市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：動物病毒檢測試劑盒市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國動物病毒檢測試劑盒市場

第18章：中國動物病毒檢測試劑盒市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Heska Corporation
  • Luminex Corporation
  • Merck KGaA
  • Neogen Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-2B5802CFE8EA

The Animal Virus Detection Kit Market was valued at USD 1.55 billion in 2025 and is projected to grow to USD 1.71 billion in 2026, with a CAGR of 11.28%, reaching USD 3.27 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.55 billion
Estimated Year [2026] USD 1.71 billion
Forecast Year [2032] USD 3.27 billion
CAGR (%) 11.28%

Framing the urgent strategic context for animal virus diagnostic kit innovation and deployment across diverse veterinary and surveillance ecosystems

The animal virus detection kit landscape now sits at the intersection of technological innovation, public health urgency, and sectoral transformation. Diagnostic capabilities that were once confined to centralized laboratories are rapidly migrating toward field-deployable formats, driven by the need for faster detection, early containment, and integrated surveillance across animal and human health domains. As pathogens continue to emerge and re-emerge, stakeholders from veterinary clinics to research institutes must navigate a complex array of platforms, sample types, and regulatory environments in order to maintain effective disease control and safeguard supply chains.

Adoption drivers include the push for rapid point-of-care diagnostics, the proliferation of multiplex and high-sensitivity assays, and growing expectations for interoperability with digital health infrastructure. At the same time, end users face constraints related to sample logistics, cold chain management, and variable laboratory capacity, which emphasize the need for robust, user-friendly kits that perform reliably across diverse settings. In this context, the industry's strategic choices around technology selection, distribution models, and validation pathways will determine which solutions achieve sustained adoption and deliver measurable impact on animal health outcomes.

How converging technological breakthroughs and operational innovations are rapidly redefining diagnostic performance expectations and deployment strategies in animal health

Recent years have delivered a set of transformative shifts that are reshaping how animal virus detection kits are developed, validated, and deployed. Advances in molecular biology, particularly the maturation of CRISPR-based diagnostics and improvements in isothermal amplification techniques, have lowered the technical threshold for highly specific, rapid assays, enabling decentralization of testing away from centralized reference labs. Concurrently, next generation sequencing platforms have become more accessible and flexible, allowing for comprehensive pathogen surveillance and the rapid characterization of novel variants, which informs both diagnostic design and outbreak response.

Operationally, there is a clear pivot toward integrated diagnostic workflows that link sample collection, in-field testing, and cloud-based data aggregation to support real-time decision-making. This trend is reinforced by investments in automation, digital result reporting, and AI-enabled analytics that improve interpretation and trend detection. Regulatory frameworks are also evolving to accommodate emergency use pathways and pragmatic validation strategies, which accelerates time-to-adoption for novel assays while emphasizing the need for robust clinical evidence. Taken together, these shifts favor diagnostic solutions that balance analytical performance with ease of use, supply chain resilience, and seamless data integration across public health and veterinary networks.

Evaluating the wide-ranging supply chain, pricing, and strategic consequences of U.S. tariff policy adjustments on animal diagnostic kit sourcing and commercialization

Policy changes that alter cross-border trade dynamics have a direct and consequential impact on the animal virus detection kit supply chain and commercial strategies. Tariff adjustments implemented by the United States in 2025 have prompted manufacturers and distributors to reassess sourcing strategies, manufacturing footprints, and pricing models. These changes increase the salience of local production capabilities and strategic stockpiling as mechanisms to mitigate import cost volatility and ensure continuity of supply for critical diagnostic inputs such as enzymes, cartridges, and reagents.

In response, many stakeholders have accelerated localization efforts, diversified supplier relationships, and negotiated longer-term contracts to buffer against tariff-driven cost fluctuations. For research-oriented organizations and smaller suppliers, elevated import costs can constrict margins and slow the pace of field validation studies unless offset by operational efficiencies or new funding sources. Conversely, distributors and end users have shown increased interest in bundled services and integrated supply agreements that stabilize procurement. Overall, the tariff environment has reinforced the need for flexible manufacturing strategies, transparent cost modeling, and proactive regulatory engagement to preserve affordability and access to high-quality diagnostic kits.

Comprehensive segmentation-driven product and go-to-market imperatives that align technology, animal species, sample logistics, and distribution pathways for diagnostic success

A nuanced understanding of segmentation is essential for developers and commercial teams to align product features with end-user needs and operational realities. Across technology, options span CRISPR-based approaches with Cas12 and Cas13 variants that offer high specificity and potential for rapid lateral-flow integrations; enzyme-linked immunosorbent assays available in competitive, indirect, and sandwich formats that remain foundational for antigen and antibody detection; loop mediated isothermal amplification platforms including lateral flow LAMP and real-time LAMP that support field-friendly amplification without complex thermocyclers; next generation sequencing split between long read and short read strategies that enable both comprehensive pathogen discovery and targeted surveillance; and polymerase chain reaction platforms differentiated into digital PCR and real-time PCR formats that continue to set benchmarks for analytical sensitivity.

Animal type segmentation directs where kit performance and usability matter most, with aquaculture applications focused on fish and shrimp diagnostics that contend with unique sampling matrices; companion animal testing prioritizing cats and dogs in clinical and preventive contexts; livestock diagnostics serving cattle, ovine, and swine populations where herd-level surveillance and rapid herd management decisions are paramount; and poultry diagnostics tailored for chicken, ducks, and turkey operations with high throughput and environmental sampling considerations. End users vary from diagnostic labs-both private and public health laboratories-that demand standardized workflows and regulatory-grade validation, to farms and veterinary clinics that require simple, robust kits for routine screening, to research institutes that need flexible platforms for method development. Sample type specificity drives assay design, with blood matrices divided into plasma, serum, and whole blood; swab-based collection encompassing nasal, oral, and rectal sampling strategies; and fecal and tissue samples requiring specialized extraction protocols. Distribution channels range from direct sales and distributor networks to online platforms, each imposing different requirements for packaging, cold chain logistics, and customer support. Finally, virus type considerations-DNA and RNA pathogens, each with enveloped and non-enveloped subclasses-inform extraction chemistry, assay stability, and biosafety handling protocols. Together, these segmentation dimensions create a mosaic of product requirements that manufacturers must address through targeted design choices, validation strategies, and go-to-market models.

Regional adoption patterns and infrastructure contrasts that determine validation pathways, distribution models, and surveillance collaboration across global veterinary markets

Regional dynamics shape technology adoption curves, regulatory expectations, and supply chain resilience in distinct ways that companies must navigate deliberately. In the Americas, established laboratory networks, strong veterinary infrastructure, and integrated supply channels favor the uptake of high-throughput platforms and validated assay portfolios, while there is simultaneous demand for point-of-care solutions in remote agricultural regions. In Europe, Middle East & Africa, regulatory heterogeneity and varying laboratory capacity create opportunities for flexible validation strategies and modular platforms that can be tailored to local approval pathways and resource constraints. Additionally, the diverse agricultural practices across the region underline the need for adaptable sample collection and training programs.

The Asia-Pacific region presents a dual imperative: high-volume production and intensive aquaculture operations drive demand for scalable diagnostics, while rapid adoption of mobile and decentralized testing favors isothermal and CRISPR-based point-of-care solutions. Regional supply chain hubs in parts of Asia also offer manufacturing and distribution advantages, but they require rigorous quality control to meet exporting nations' regulatory standards. Cross-region collaboration and harmonization efforts are increasingly important, as data sharing and coordinated surveillance enhance early detection and response capabilities across borders.

Profiles of competitive advantage that combine rapid assay innovation, rigorous validation practices, scalable manufacturing, and partnership ecosystems to drive adoption

Competitive dynamics in this sector are shaped less by sheer scale and more by the ability to integrate technical innovation with real-world validation, regulatory clarity, and reliable supply chains. Leading organizations demonstrate capabilities in rapid assay development, robust analytical and clinical validation, and the capacity to scale manufacturing while maintaining stringent quality controls. Partnerships between assay developers, instrument manufacturers, and distribution specialists are commonplace, enabling faster market access and broader service offerings that combine kits with consumables, instrumentation, and digital reporting tools.

In addition, companies that invest in comprehensive field studies, third-party validations, and transparent performance data tend to build greater trust among end users and regulatory bodies. Service-oriented business models that include training, on-site support, and data management services differentiate offerings in markets where technical expertise varies. Strategic collaborations with academic and public health institutions further strengthen credibility and accelerate adoption by demonstrating real-world utility in surveillance and outbreak scenarios. Ultimately, the competitive edge emerges from a balanced focus on innovation, operational excellence, and partnership networks that deliver measurable improvements in diagnostic workflows and animal health outcomes.

Actionable strategic moves for companies to translate diagnostic innovation into resilient supply models, rapid validation, and sustained end-user adoption across diverse environments

Industry leaders should prioritize a set of concrete actions to convert technological promise into sustained field impact. First, investing in modular platforms that support multiple assay chemistries reduces time to market for new targets and provides customers with a future-proofed solution. Second, building regional manufacturing and distribution redundancies mitigates the risk of tariff-induced cost shocks and supply interruptions, while targeted inventory strategies preserve continuity for critical reagents. Third, accelerating validation through well-structured field studies and third-party evaluations enhances credibility and shortens procurement cycles among diagnostic labs and large-scale producers.

Furthermore, companies should develop clear regulatory engagement plans that anticipate regional differences and leverage harmonized data packages wherever possible. Strengthening user experience through simplified workflows, intuitive result interpretation, and integrated digital reporting increases uptake among non-specialist end users. Partnering with training providers and veterinary networks ensures correct use and amplifies the value proposition. Finally, organizations should adopt flexible commercial models-such as bundled services, reagent rental, and outcome-based agreements-that align incentives with customers and foster long-term relationships across the veterinary ecosystem.

Robust mixed-methods research approach combining expert interviews, technical validation synthesis, supply chain mapping, and regulatory analysis to underpin actionable insights

The research underpinning this analysis combines structured primary engagement with secondary evidence synthesis to ensure both depth and practical relevance. Primary research incorporated targeted interviews with veterinary diagnosticians, laboratory directors, farm operations managers, and R&D leaders to capture end-user priorities, validation challenges, and procurement preferences. These qualitative inputs were triangulated with protocol reviews, peer-reviewed literature, and regulatory guidance to map technological readiness levels and validation expectations. Technical performance attributes were evaluated through synthesis of assay validation studies and instrument specifications to assess suitability across sample types and use scenarios.

Secondary research included systematic reviews of scientific publications, patent filings, and public health surveillance announcements to identify innovation trajectories and emergent threats. Supply chain analysis combined supplier mapping, logistics considerations, and policy review to determine factors affecting availability and cost. Throughout, findings were validated via iterative expert consultations and cross-checked against real-world deployment case studies to ensure practical applicability. Quality controls included methodological transparency, source corroboration, and peer review by subject matter experts to support the robustness of conclusions and recommendations.

Integrated diagnostic performance, supply chain resilience, and stakeholder collaboration as the determinative factors for future success in animal health surveillance

The converging pressures of pathogen emergence, technological progress, and shifting trade dynamics require a coordinated response from diagnostic developers, distributors, and end users. Success in the animal virus detection kit sector hinges on the ability to deliver analytically robust assays that are operationally feasible across diverse sample matrices and end-user settings. Equally important is the cultivation of resilient supply chains and adaptable commercial strategies that anticipate policy shifts and regional differences. When paired with rigorous field validation and targeted training, these elements create a compelling value proposition that accelerates adoption and strengthens surveillance systems.

Looking forward, the most effective solutions will be those that integrate high-performance chemistry with accessible workflows, transparent performance data, and digital interoperability. Collaboration across public and private stakeholders will amplify the impact of diagnostics on animal health outcomes and, by extension, on food security and public health. Strategic investments in modular platforms, regional manufacturing, and end-user support will be decisive in determining which organizations lead the next phase of diagnostic innovation and implementation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Virus Detection Kit Market, by Technology

  • 8.1. Cripr Based
    • 8.1.1. Cas12
    • 8.1.2. Cas13
  • 8.2. Enzyme Linked Immunosorbent Assay
    • 8.2.1. Competitive
    • 8.2.2. Indirect
    • 8.2.3. Sandwich
  • 8.3. Loop Mediated Isothermal Amplification
    • 8.3.1. Lateral Flow LAMP
    • 8.3.2. Real Time LAMP
  • 8.4. Next Generation Sequencing
    • 8.4.1. Long Read
    • 8.4.2. Short Read
  • 8.5. Polymerase Chain Reaction
    • 8.5.1. Digital PCR
    • 8.5.2. Real Time PCR

9. Animal Virus Detection Kit Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shrimp
  • 9.2. Companion Animals
    • 9.2.1. Cats
    • 9.2.2. Dogs
  • 9.3. Livestock
    • 9.3.1. Cattle
    • 9.3.2. Ovine
    • 9.3.3. Swine
  • 9.4. Poultry
    • 9.4.1. Chicken
    • 9.4.2. Ducks
    • 9.4.3. Turkey

10. Animal Virus Detection Kit Market, by Sample Type

  • 10.1. Blood
    • 10.1.1. Plasma
    • 10.1.2. Serum
    • 10.1.3. Whole Blood
  • 10.2. Fecal
  • 10.3. Swab
    • 10.3.1. Nasal
    • 10.3.2. Oral
    • 10.3.3. Rectal
  • 10.4. Tissue

11. Animal Virus Detection Kit Market, by Virus Type

  • 11.1. DNA
    • 11.1.1. Enveloped
    • 11.1.2. Non Enveloped
  • 11.2. RNA
    • 11.2.1. Enveloped
    • 11.2.2. Non Enveloped

12. Animal Virus Detection Kit Market, by End User

  • 12.1. Diagnostic Labs
    • 12.1.1. Private Labs
    • 12.1.2. Public Health Labs
  • 12.2. Farms
  • 12.3. Research Institutes
  • 12.4. Veterinary Clinics

13. Animal Virus Detection Kit Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Platforms

14. Animal Virus Detection Kit Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Animal Virus Detection Kit Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Animal Virus Detection Kit Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Animal Virus Detection Kit Market

18. China Animal Virus Detection Kit Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Agilent Technologies, Inc.
  • 19.7. Bio-Rad Laboratories, Inc.
  • 19.8. Danaher Corporation
  • 19.9. Heska Corporation
  • 19.10. Luminex Corporation
  • 19.11. Merck KGaA
  • 19.12. Neogen Corporation
  • 19.13. PerkinElmer, Inc.
  • 19.14. QIAGEN N.V.
  • 19.15. Roche Diagnostics International AG
  • 19.16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS12, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS12, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS12, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS13, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS13, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS13, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SANDWICH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LATERAL FLOW LAMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LATERAL FLOW LAMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LATERAL FLOW LAMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME LAMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME LAMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME LAMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LONG READ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LONG READ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LONG READ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHORT READ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHORT READ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHORT READ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FISH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FISH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FISH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHRIMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY OVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY OVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY OVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CHICKEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CHICKEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CHICKEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DUCKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DUCKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DUCKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TURKEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TURKEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TURKEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FECAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FECAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FECAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PRIVATE LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PRIVATE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PUBLIC HEALTH LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PUBLIC HEALTH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. MIDDLE EA